Salicylic acid

Description

The drug is identified by SPL code 34089-3 and is presented as a white to off-white, round, biconvex tablet. It is imprinted with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the treatment of acne and the prevention of breakouts. It effectively removes blackheads and minimizes the appearance of pores. Additionally, it gently exfoliates dead skin cells, leading to improved skin texture and tone.

Limitations of Use: There are no specific teratogenic or nonteratogenic effects associated with this drug as per the available data.

Dosage and Administration

Healthcare professionals should instruct patients to cleanse and dry the face thoroughly prior to application. The product should be applied by gently wiping the pad over the affected areas, taking care to avoid the eye contour.

For normal skin, the recommended usage is once daily, preferably in the evening. For individuals with sensitive skin, it is advised to use the product every other day. Following the application, patients should apply a moisturizer to enhance skin hydration.

First-time users are encouraged to conduct a patch test on a small area of skin before proceeding with full application to assess tolerance.

Contraindications

Use of this product is contraindicated in the following situations:

• Patients with a known allergy to salicylic acid or any other ingredient in the formulation.

• Application on broken, sunburned, or otherwise irritated skin is not recommended due to the potential for exacerbation of the condition.

• Concurrent use with other acne medications containing salicylic acid is contraindicated unless specifically directed by a healthcare professional, as this may increase the risk of adverse effects.

Warnings and Precautions

The use of this product is contraindicated on injured wounds, as application may exacerbate the condition and impede healing.

Healthcare professionals should exercise caution when prescribing this medication to patients with a known allergy to salicylic acid or any of its components. Additionally, the product should not be applied to broken, sunburned, or otherwise irritated skin, as this may lead to increased irritation or adverse reactions. Co-administration with other acne treatments containing salicylic acid is not recommended unless specifically directed by a healthcare provider.

Patients should be advised to discontinue use and consult their physician if they experience severe irritation, rash, or peeling of the skin. Furthermore, if there is no observable improvement after 12 weeks of consistent use, medical advice should be sought. Signs of an allergic reaction, such as swelling, itching, or difficulty breathing, warrant immediate medical attention.

In the event of ingestion, it is critical to seek emergency medical assistance by contacting Poison Control at 1-800-222-1222 in the U.S. to ensure appropriate management of the situation.

Side Effects

Patients using this product should be aware of several important adverse reactions. Severe irritation, rash, or peeling may develop during treatment. In the event that no improvement is observed after 12 weeks of regular use, it is advised to discontinue use and consult a healthcare professional.

Additionally, patients should be vigilant for signs of an allergic reaction, which may include swelling, itching, or difficulty breathing. It is crucial to avoid using this product on injured wounds, as this may exacerbate adverse effects.

Drug Interactions

Concurrent use of this medication with other acne treatments containing salicylic acid is not recommended unless specifically directed by a healthcare professional. The combination may increase the risk of adverse effects, including skin irritation and excessive dryness. It is advisable to consult a physician for appropriate management and to consider alternative therapies if necessary. Monitoring for signs of increased irritation or other adverse reactions is recommended if co-administration occurs.

Packaging & NDC

Below are the non-prescription pack sizes of Acne Treatment Cotton Pads. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

There is no specific pediatric use information available for this medication, including recommended ages, dosing differences, safety concerns, or special precautions for children. Healthcare professionals should exercise caution when considering the use of this medication in pediatric patients due to the absence of relevant data.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The available prescribing information does not provide specific data regarding the use of this product during pregnancy. Consequently, the safety concerns, dosage modifications, or special precautions for pregnant patients remain undefined. Healthcare professionals should exercise caution when prescribing this product to women of childbearing potential and consider the lack of information when evaluating the potential risks and benefits for pregnant patients. It is advisable to monitor any emerging data that may inform the safety profile of this product in the context of pregnancy.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any considerations related to lactation. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established, and further research may be necessary to determine the safety profile in this population.

Renal Impairment

Dosage adjustments may be necessary for patients with reduced renal function. Regular monitoring of renal function tests is recommended for patients with known kidney problems. A reduced dose should be considered for patients with a creatinine clearance of less than 30 mL/min. Additionally, special monitoring is required for patients with severe renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no information available regarding overdosage for this medication. Healthcare professionals are advised to monitor patients closely for any signs of adverse effects or symptoms that may arise from potential overdosage. In the absence of specific data, it is recommended that standard supportive measures be employed in the event of suspected overdosage.

In cases where overdosage is suspected, healthcare providers should assess the patient's clinical status and provide symptomatic treatment as necessary. It is essential to consult local poison control centers or relevant medical authorities for guidance on management protocols tailored to the specific circumstances of the overdose.

Continued vigilance and appropriate clinical judgment are crucial in managing any potential overdosage scenarios effectively.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that the product contains salicylic acid, which can be harmful if swallowed. Instruct patients to contact Poison Control immediately if ingestion occurs, providing the U.S. Poison Control number: 1-800-222-1222.

Patients may experience mild tingling or redness upon initial application; however, they should be counseled to discontinue use if these sensations become severe. It is important to inform patients to avoid sun exposure after using the product and to apply sunscreen daily to protect their skin.

Additionally, healthcare providers should recommend that patients refrain from combining this product with harsh scrubs or alcohol-based products, as this may exacerbate skin irritation. Lastly, patients should be cautioned to keep the product away from their eyes and mucous membranes to prevent adverse effects.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at a temperature range of 15-25°C (59-77°F). The shelf life of the product is 24 months when unopened; however, it should be discarded if the pads dry out. Additionally, the cotton pads are biodegradable, and the outer packaging is recyclable, promoting eco-friendly practices.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Acne Treatment Cotton Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)